Corporate Banner
Satellite Banner
Next Gen Sequencing
Scientific Community
Become a Member | Sign in
Home>News>This Article

PerkinElmer and MGH Pathology Collaborate

Published: Wednesday, September 12, 2012
Last Updated: Wednesday, September 12, 2012
Bookmark and Share
Collaboration to develop a complete sequencing informatics system for cancer research.

PerkinElmer, Inc. has announced that it has entered into a collaboration with Dr. John Iafrate and Dr. Long Le of the Massachusetts General Hospital (MGH) Pathology Department and Cancer Center to develop a sequencing informatics system for profiling the genetic changes in tumors for use in advanced cancer research.

Based on PerkinElmer’s Geospiza® informatics platforms, the new system is expected to help guide the development of cancer treatments by enabling genotype analysis to define key genetic targets from which clinically relevant information can be leveraged.

Under the terms of the agreement, PerkinElmer will develop a highly automated sample preparation and data analysis system suitable for cancer genotyping in clinical research at the MGH Pathology Department and Cancer Center.

PerkinElmer’s Geospiza GeneSifter® Laboratory and Analysis edition software platform will be enhanced with sophisticated variant detection algorithms.

The new system will also integrate existing laboratory processes and equipment with enhanced LIMS and data analysis capabilities.

The informatics system will support the cancer research of Dr. Long Le and Dr. John Iafrate of the MGH Pathology Department and Cancer Center.

“A key challenge presented by next generation sequencing applications in clinical research is not only maintaining high efficiency and throughput via automation solutions, but also ensuring that the informatics driving the instrumentation provides transparency and traceability for the entire process,” said Dr. Le.

Kevin Hrusovsky, president of Life Sciences & Technology at PerkinElmer, said, “Working with the MGH Pathology Department and Cancer Center to support their critically important cancer research is a deeply rewarding collaboration and is consistent with our goal to help researchers eradicate this deadly disease. We are delighted to provide MGH with a complete next generation sequencing informatics and sample preparation solution to help advance their medical research.”

The MGH Pathology Department and Cancer Center are currently using the high quality service and data from PerkinElmer’s DNA Sequencing Services group and deploys PerkinElmer’s Sciclone® automated liquid handling platform and the NGS Express™ Workstation for benchtop sequencers.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Good Start Genetics, PerkinElmer Collaboration Expands Access to Genetic Carrier Screening Tests
Strategic agreement will broaden access to GoodStart Select™ tests to include obstetrics and gynecology and maternal fetal medicine physicians.
Monday, March 17, 2014
PerkinElmer Announces Strategic Alliance with Integromics
PerkinElmer becomes the sole worldwide distributor of Integromics’ software for the TIBCO Spotfire.
Tuesday, June 25, 2013
PerkinElmer to Host Revolutionaries for Global Health Summit
Company to assemble thought leaders to share pioneering personalized health research and innovations.
Wednesday, May 01, 2013
PerkinElmer Announces Collaboration with Rutgers University Cell and DNA Repository
Companies team up to enable large-scale sequencing studies through more efficient automation and improving next generation sequencing sample access.
Tuesday, February 21, 2012
Scientific News
Research at St Thomas’s Hospital Exploring Causative Factors of Atopic Eczema and Food Allergy in Infants
Carsten Flohr and his research group at St Thomas’s hospital, London are currently investigating the interaction between skin and gut microbiota in relation to the associated risk of atopic eczema (AE) and food allergy in infants.
Gut Bacteria Can Dramatically Amplify Cancer Immunotherapy
Manipulating microbes maximizes tumor immunity in mice.
Proteins Crucial to Loss of Hearing Identified
Proteins play key role in genes that help auditory hair cells grow.
New Virus Identified In Blood Supply
Scientists have discovered a new virus that can be transmitted through the blood supply.
Far-reaching Genetic Study of 1,000 UK People
300,000 gene variants from 1,000 people made publically available via F1000Research.
DNA Alterations as Among Earliest to Occur in Lung Cancer Development
Genetic footprints of precancer detectable in some blood samples.
Targeting DNA
Protein-based sensor could detect viral infection or kill cancer cells.
Genetic Sleuthing
Sabeti team applies Ebola methods to shed light on spread of Lassa fever.
Seeking “Gold Standard” Wastewater Treatments
Metagenomic analyses lend insights into how microbes break down wastewater contaminants.
Using Genetic Sequencing to Manage Cancer in Children
A team of scientists have investigated the feasibility of incorporating clinical sequencing information into the care of young cancer patients.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos